Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P. Abbott Laboratories Transaction History

Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P.

$653 Million
Q3 2024

A detailed history of Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P. transactions in Abbott Laboratories stock. As of the latest transaction made, Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P. holds 16,653 shares of ABT stock, worth $1.93 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

16,653

Previous 16,699 0.28%

Holding current value

$1.93 Million

Previous $1.74 Million 9.39%

% of portfolio

0.29%

Previous 0.37%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $4,603 - $5,433	-46 Reduced 0.28%	16,653 $1.9 Million
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $6,043 - $6,746	-60 Reduced 0.36%	16,699 $1.74 Million
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $1,533 - $1,693	-14 Reduced 0.08%	16,759 $1.9 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $7,215 - $8,832	-80 Reduced 0.47%	16,773 $1.85 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $6,489 - $7,638	67 Added 0.4%	16,853 $1.71 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $46,769 - $54,867	-492 Reduced 2.85%	16,786 $1.84 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $116,870 - $141,258	-1,145 Reduced 6.22%	17,278 $1.88 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $57,010 - $69,520	-500 Reduced 2.64%	18,423 $2.18 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $15,018 - $18,389	-130 Reduced 0.68%	18,923 $2.66 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $2,721 - $3,205	-25 Reduced 0.13%	19,053 $2.28 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $84,000 - $91,536	800 Added 4.38%	19,078 $2.09 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $40,779 - $49,524	445 Added 2.5%	18,278 $1.99 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $14,134 - $20,668	-225 Reduced 1.25%	17,833 $1.41 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $11,776 - $13,110	-150 Reduced 0.82%	18,058 $1.57 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $104,958 - $126,895	-1,585 Reduced 8.01%	18,208 $1.46 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $15,931 - $18,047	243 Added 1.24%	19,793 $1.43 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $50,472 - $60,888	-830 Reduced 4.07%	19,550 $1.43 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $17,328 - $19,125	-301 Reduced 1.46%	20,380 $1.24 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $5,627 - $6,362	100 Added 0.49%	20,681 $1.24 Million
Q3 2017 Nov 09, 2017	BUY	$48.06 - $53.64 $989,122 - $1.1 Million	20,581	20,581 $1.1 Million

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P. with notifications on news.

Account

Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P. Abbott Laboratories Transaction History